Patheon

As a leading #CDMO, Thermo Fisher Scientific offers comprehensive #drugdevelopment and manufacturing capabilities for #oralsoliddose (#OSD) products across nine sites worldwide. From #formulationdevelopment to scale-up and #commercialmanufacturing, our end-to-end solutions support #biotech and #pharma companies through every phase of the product lifecycle. To learn more about our #OSD services and solutions, download our capabilities brochure: http://spr.ly/6041trbkU

#Timetomarket is crucial in #clinicaltrials, and Thermo Fisher Scientific’s global label services are designed to streamline the process. With integrated facilities and advanced information systems, we offer enhanced visibility and control across the clinical #supplychain. Our #Basel, Switzerland site, part of Thermo Fisher Scientific’s global #cGMP network, serves as a key location for both #packaging and #labeling services in #Europe. Continued investment in this site reflects our focus on delivering timely and efficient label solutions. Learn more about our #Basel site here: http://spr.ly/6046tRNg4

#Peptides have the potential to treat conditions like cancer, autoimmune diseases, and metabolic disorders—but #oraldelivery remains a challenge. Traditionally, most #peptides are administered via injection due to poor #bioavailability, which can impact #patientcompliance, as well as #accessibility. Luckily, progress is being made toward overcoming this barrier. Join Anil Kane, Ph.D., MBA, Ph.D., MBA, of Thermo Fisher Scientific, in an upcoming webinar as he explores this topic and offers valuable insight into the following areas: • Barriers to #oralpeptidedelivery and the science behind them • Innovations transforming the field of oral peptide therapeutics • The potential for expanded applications through #oraldelivery • How to navigate #regulatoryhurdles and #acceleratedevelopment Register here: http://spr.ly/6046tKLjG

From natural disasters to geopolitical tensions and regulatory changes, today’s #biotech and #pharma companies face more #supplychain risks than ever before. Our new #whitepaper explores the evolution of these challenges over the past 15 years, offering insights on how to manage and mitigate disruptions to #drugdevelopment. Key insights include: ▶️ How recent global events have exposed vulnerabilities in the #supplychain ▶️ Best practices for strategic #materialssourcing and supplier #riskmanagement ▶️ Tips for cultivating industry partnerships for long-term #supplychain stability ▶️ Practical steps to stay proactive in an unpredictable market environment Additionally, learn how Thermo Fisher Scientific’s #CDMO and #CRO solutions help our partners stay ahead of challenges and seize opportunities for improvement. Download the whitepaper here: http://spr.ly/6048tKnbQ

From global vaccines to personalized cancer therapies, #mRNA is being explored across clinical applications, each with varying requirements for production scale and final dosage. This drives the need for #flexiblemanufacturing processes, enabling #drugdevelopers to consistently deliver high yields of quality #mRNA efficiently while balancing logistical and financial considerations. Thermo Fisher Scientific provides a flexible solutions model for mRNA-based products, spanning the entire operational #valuechain. Read our recent article on Fierce Pharma to learn how working with an adaptable, collaborative #CDMO partner can help you successfully navigate industry challenges and bring your unique #mRNAvaccine or #therapeutic to market faster. Read it here: http://spr.ly/6040sA0U0

With #healthcaredemand surging due to an aging population and other critical factors, the need to accelerate innovation in #drugdevelopment has never been greater. Thermo Fisher Scientific’s new Accelerator™ Drug Development approach combines #CDMO and #CRO solutions in one streamlined service to bring treatments to patients faster. Learn more about this end-to-end offering for #biotech and #pharma #drugdevelopers in our blog, “Redefining acceleration of the #drugdevelopment journey”: http://spr.ly/6044sALLp

Today’s #biotech and #pharma sponsors are facing rising costs, increased competition, and pressure to innovate faster than ever. To stay ahead, maximizing value at every stage of #drugdevelopment is critical—from early-stage research to #clinicaltrials and #commercialization. Join Thermo Fisher Scientific for an upcoming webinar where we’ll share findings from the Tufts Center for the Study of Drug Development on how integrating end-to-end #CDMO and #CRO services and solutions can significantly boost your program's #expectedNetPresentValue (eNPV). In this webinar, you'll learn: ▶️ The benefits of leveraging #eNPV modeling for combined #CDMO and #CRO services ▶️ How to streamline processes with #ThermoFisher’s Accelerator™ Drug Development ▶️ Real-world case studies showcasing successes from #biotech and #pharma sponsors Led by Dr. Joseph DiMasi from Tufts University , as well as Brenda Bruker and Brittany Hall from Thermo Fisher Scientific , this is a can’t-miss event. RSVP by clicking below: http://spr.ly/6046s04P0

Regulatory rejections of #NewDrugApplications (#NDAs) can often be linked to #clinicaltrial labeling issues. That’s why it’s essential to partner with an expert to ensure your labels are accurate and delivered on time, every time. Thermo Fisher Scientific offers integrated #print and #label solutions, along with packaging, #supplychain, and logistics services, all designed to reduce #cycletimes and meet your clinical trial timelines. Our capabilities include: ▶️ Label printing in 4-5 days, with expedited orders available upon request ▶️ Pre-qualified options for a variety of #primary and #secondary packaging ▶️ Labels for a range of temperature needs, including frozen and #cryogenic ▶️ Qualified materials for specific applications and storage temperatures ▶️ Durable, fully laminated #clinicaltrial labels that protect #dataintegrity To explore our #clinicallabel services in detail, including our global network of production sites, click here: http://spr.ly/6041siAfJ

#Smallmoleculedrugs are a cornerstone of #modernmedicine, accounting for 69% of all new FDA-approved drugs in 2023. However, despite their prevalence, their #development and #manufacturing processes aren’t always straightforward. Our latest blog dives into this topic in-depth, covering the essentials of #smallmolecule drugs, including their: ▶️ Key characteristics ▶️ Unique advantages ▶️ Impact on patients It also examines how a #CDMO partner like Thermo Fisher Scientific can provide comprehensive #drugdevelopment support. Read it here: http://spr.ly/6049sgRbH

Emerging technologies like #artificialintelligence (#AI) and #predictivemodeling are reshaping the #pharmaceutical landscape, offering precise, data-driven insights that streamline #drugdevelopment and enhance #patientoutcomes. At Thermo Fisher Scientific, our patient-centric approach focuses on solutions that improve medication accessibility and efficacy. In a recent article, Sanjay Konagurthu, senior director of science and innovation for #drugproduct and #pharmaservices, shares how we leverage these technologies to tackle challenges like #solubility and #bioavailability early in the #oralsoliddose (#OSD) formulation process. Read the article on Contract Pharma to learn how these innovations not only accelerate the journey from #discovery to #delivery but also help life-saving therapies reach patients faster: http://spr.ly/6041srVlP